Anika Therapeutics, Inc.
ANIK· Nasdaq
ANIKAnika Therapeutics, Inc.
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2017 | Q4 2016 | Q4 2015 | Q4 2014 |
|---|---|---|---|---|
| Revenue | $29.39M | $28.73M | $30.89M | $23.26M |
| Net Income | $8.07M | $8.09M | $11.04M | $7.82M |
| EPS Diluted | $0.53 |
Anika Therapeutics, Inc. · CIK 898437 · Engraved from SEC EDGAR
| $0.54 |
| $0.72 |
| $0.51 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
